Concepedia

Publication | Open Access

Dersimelagon, a novel oral melanocortin 1 receptor agonist, demonstrates disease-modifying effects in preclinical models of systemic sclerosis

27

Citations

33

References

2022

Year

References

YearCitations

Page 1